Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs

Folia Pharmacologica Japonica

Volumn 108, Issue 2, 1996, Pages 39-48

  Fujikura, Naoki ^a   Yokoyama, Tatsuro ^a   Masuda, Yukinori ^a   Shikada, Ken Ichi ^a   Tanaka, Sakuya ^a  

^a NISSAN CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EFONIDIPINE; NIFEDIPINE; NISOLDIPINE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL OXYGEN TENSION; ARTICLE; CONTROLLED STUDY; CORONARY SINUS BLOOD FLOW; DOG; HEART MUSCLE OXYGEN CONSUMPTION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; VENOUS OXYGEN TENSION;

EID: 0029759345     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.108.39     Document Type: Article

References (27)

1. Fleckenstein A: Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol 17, 149-166 (1977)
2. Gross GJ, Warltier DC and Hardman HF: Comparative effects of FR 34235, a new slow channel calcium blocker, and nifedipine on hemodynamics and myocardial oxygen consumption in the anesthetized dog. Gen Pharmacol 14, 677-680 (1983)
3. Kazda S, Garthoff B, Meyer H, Schloßmann K, Stoepel K, Towart R, Vater W and Wehinger E: Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1, 4-dihydro-2, 6-dimethyl-4-(2-nitrophenyl)-3, 5-pyridinedicarboxylate (nisoldipine, BAY k 5552). Arzneimittelforschung 30, 2144-2162 (1980)
4. Nitrendipine 92, 397-410 (1988)
5. Masuda Y, Iwama T, Yamashita T, Sakai T, Hibi M, Tanaka S, Shigenobu K and Kasuya Y: Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta. Arch Int Pharmacodyn Ther 312, 86-103 (1991)
6. Masuda Y, Takeguchi M, Arakawa C, Sakai T, Hibi M, Tanaka S, Shigenobu K and Kasuya Y: Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative. Arch Int Pharmacodyn Ther 304, 247-264 (1990)
7. Shudo C, Masuda Y, Sakai T, Tanaka S, Shigenobu K and Kasuya Y: Studies on the hypotensive mechanisms of NZ-105, a new dihydropyridine derivative, in rats and rabbits. Gen Pharmacol 24, 411-418 (1993)
8. 8) Dihydropyridine, (±)-2-[benzyl (phenyl) amino] ethyl 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-4- (3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) 42, 43-54 (1991)
9. (±)-2-[benzyl(phenyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-4- (3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) 42, 55-60 (1991)
10. Masuda Y, Iwama T, Yamashita T, Sakai T, Hibi M, Tanaka S, Shigenobu K and Kasuya Y: Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro. Arch Int Pharmacodyn Ther 314, 57-73 (1991)
11. Kimura Y, Fukui H, Tanaka M, Okamoto M, Miura A, Kimura K and Enomoto H: Cardiovascular effects of a new dihydropyridine calcium antagonist. Arzneimittelforschung 36, 1336-1344 (1986)
12. Chibana T, Noguchi K, Ojiri Y and Sakanashi M: Comparative studies of the systemic hemodynamics and myocardial oxygen consumption of FRC 8653, a new Ca channel blocker, and nifedipine in anesthetized dogs. Jpn Heart J 33, 239-252 (1992)
13. Tamura T, Saigusa A and Kokubun S: Mechanisms underlying the slow onset of action of a new dihydropyridine, NZ-105, on a cultured smooth muscle cell line. Naunyn Schmiedebergs Arch Pharmacol 343, 405-410 (1991)
14. Yamashita T, Masuda Y, Sakai T, Tanaka S and Kasuya Y: NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta. Jpn J Pharmacol 57, 337-348 (1991)
15. Toribatake T, Fujii K, Kobayashi M, Okumura M and Aikawa K: Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(odifluoromethoxyphenyl) - 1, 4 - dihydropyricline (PP-1466). Arzneimittelforschung 35, 680-686 (1985)
16. Kanda A, Haruno A, Miyoshi K, Tanahashi Y, Miyake H, Ichihara K, Okumura K and Nagasaka M: Cardiovascular profile of MPC-1304, a novel dihydropyridine calcium antagonist: comparison with other calcium antagonists. J Cardiovasc Pharmacol 22, 167-175 (1993)
17. Uchida W, Shibasaki K, Asano M and Takenaka T: Antianginal effects of YM-16151-4 in various experimental angina models. J Cardiovasc Pharmacol 21, 701-708 (1993)
18. Jolly SR, Hardman HF and Gross GJ: Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia. J Pharmacol Exp Ther 217, 20-25 (1981)
19. Beaughard M, Michelin MT, Tisne-Versailles J and Lamar JC: Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs. Arch Int Pharmacodyn Ther 284, 276-296 (1986)
20. Duncker DJ, Hartog JM, Hugenholtz PG, Saxena PR and Verdouw PD; The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without β-adrenoceptor blockade. Br J Pharmacol 88, 9-18 (1986)
21. Hof RP: PY 108-068: A calcium antagonist with an unusual pattern of cardiovascular activity. Gen Pharmacol 16, 1-6 (1985)
22. Sakanashi M, Noguchi K, Miyamoto Y, Kato T, Nagamine F, Yu WT, Higuchi M and Nakasone J: Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs. Arch Int Pharmacodyn Ther 294, 159-174 (1988)
23. Price HL: General anesthesia and circulatory homeostasis. Physiol Rev 40, 187-218 (1960)
24. Scher AM and Young AC: Reflex control of heart rate in the unanesthetized dog. Am J Physiol 218, 780-789 (1970)
25. Vatner SF and Braunwald E: Cardiovascular control mechanisms in the conscious state. N Engl J Med 293, 970-976 (1975)
26. Takahashi K and Taira N: Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart. Arzneimittelforschung 36, 1054-1059 (1986)
27. Micheli D, Collodel A, Semeraro C, Gaviraghi G and Carpi C: Lacidipine: A calcium antagonist with potent and long-lasting antihypertensive effects in animal studies. J Cardiovasc Pharmacol 15, 666-675 (1990)